Lv6
1625 积分 2020-04-20 加入
Efficacy of Tonlamarsen in Patients with Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial
1个月前
已完结
A Comprehensive Guide to Toxicology in Nonclinical Drug Development
2个月前
已完结
RNAi-based drug design: considerations and future directions
3个月前
已完结
RNA interference in the era of nucleic acid therapeutics
3个月前
已完结
RNA chemistry and therapeutics
3个月前
已完结
siRNA-based delivery systems: Technologies, carriers, applications, and approved products
3个月前
已完结
[225Ac]Ac-PSMA I&T: A Preclinical Investigation on the Fate of Decay Nuclides and Their Influence on Dosimetry of Salivary Glands and Kidneys
5个月前
已完结
Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A
6个月前
已完结
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
7个月前
已完结
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
7个月前
已完结
皖公网安备34019202002308
